Dashboard
Analysis
Charting
Screener
Resources
Settings
CPSE-NOVO B
Jun '15
Dec '16
Jun '18
Dec '19
Jun '21
Dec '22
Jun '24
Trailing Valuation
Stock Price
437.1
619.3
993.9
698.5
552.1
470
Total Shares Outstanding
4,439.6
4,465
4,453.9
4,510
4,486.2
4,560
Market Cap
1,939,587.4
2,752,806.5
4,426,049.5
3,151,452.7
2,477,425.3
2,143,838.4
Total Enterprise Value (TEV)
2,012,974.4
2,830,490.5
4,420,458.5
3,147,156.7
2,465,658.3
2,146,224.4
Dividend Yield
—
0.6%
0.5%
0.7%
Buyback Yield
0.1%
0.4%
0.2%
Debt Paydown Yield
-1.6%
-0.7%
0%
Shareholder Yield
0.3%
-1.2%
-0.4%
P/S
12.5
17.5
33.2
25.3
23
22.9
P/Gross Profit
15
20.8
39.1
30.1
27
27.4
P/E
35
49.5
97.7
70.5
63.4
76.1
Earnings Yield
2.9%
2%
1%
1.4%
1.6%
1.3%
P/OCF
29.7
49
68.3
62.4
42.4
68.4
P/FCF
52
98.6
96.5
89.3
51.8
92.6
FCF Yield
1.9%
1.1%
P/B
11.5
19.2
39.3
29.6
25.7
EV/Sales
13
18
33.1
EV/Gross Profit
15.6
21.3
39
30
26.9
EV/EBITDA
24.9
36.3
63.6
53.2
46.7
51.9
EV/EBIT
27.9
40.1
76.5
58.6
50.4
57.6
EV/OCF
30.8
68.2
62.3
42.2
68.5
EV/FCF
54
101.3
96.4
89.2
51.6
92.7
Dividends
DPS
3.5
3.2
4.1
2.1
Payout Ratio
63.2%
28.1%
62.8%
30.2%
46.7%
34.3%
Margins
Gross Profit Margin
83.4%
84.5%
84.9%
84.2%
85.1%
83.5%
Operating Margin
46.6%
44.9%
43.3%
43.1%
45.4%
39.8%
EBITDA Margin
52.2%
49.6%
52.1%
47.5%
49%
44.1%
Net Profit Margin
35.8%
35.4%
34.1%
35.7%
36.4%
29.9%
Effective Tax Rate
21.6%
20.6%
20.2%
19.9%
18.5%
Pre-Tax Profit Margin
45.7%
44.6%
42.9%
44.7%
45.5%
36.7%
Free Cash Flow Margin
24.1%
17.8%
34.4%
28.3%
44.4%
24.7%
OCF / Sales
42.2%
48.6%
40.5%
54.2%
33.5%
OCF / Net Income
117.7%
101.1%
142.6%
113.7%
148.8%
111.9%
FCF / OCF
57%
49.7%
70.8%
69.8%
81.9%
73.9%
FCF / Net Income
67.1%
50.3%
100.9%
79.4%
121.9%
82.7%
FCF / EBITDA
46.1%
35.9%
66%
59.6%
90.6%
56%
Capital Efficiency
Return on Invested Capital
15%
18.9%
19.4%
21.3%
20.8%
Return on Assets
11.9%
14.4%
13.4%
15.4%
13.9%
Return on Equity
41.5%
46.8%
45.1%
36.3%
Return on Total Capital
52.5%
80.3%
103.6%
148.1%
137.8%
104%
Return on Capital Employed
27.6%
40%
34.6%
Return on Tangible Assets
15.2%
18.2%
16%
20%
18.7%
16.4%
Receivables Turnover
1.7
1.9
1.8
Days Sales Outstanding
214
195.4
212
196.9
217.4
204.2
Payables Turnover
0.9
0.7
1
1.3
Days Payables Outstanding
404.6
408.4
500.5
381.1
379.8
288.7
Inventory Turnover
0.6
Days Inventory Outstanding
613.4
545
616.2
519.9
596.4
519.4
Cash Conversion Cycle
422.9
332
327.8
335.7
433.9
434.9
Asset Turnover
0.3
0.4
Fixed Asset Turnover
1.2
1.6
1.5
Operating Cycle
827.4
740.4
828.2
716.8
813.7
723.6
CapEx to OCF
0.5
0.2
CapEx to Revenue
0.1
CapEx to Depreciation
3.8
2.8
2.7
2
Financial Health
Total Debt
104,597
110,318
59,423
28,278
27,243
28,687
Net Debt
73,387
77,684
-5,591
-4,296
-11,767
2,386
Current Ratio
0.8
Quick Ratio
Cash Ratio
Debt Ratio
Assets to Equity
2.9
3.3
3
3.1
Cash Flow to Debt Ratio
1.1
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-151,382
-161,412
-79,361
-68,279
-52,729
-49,577
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-0.1
-0.2
EBIT / Interest Expense
7.1
19
15.9
145.1
102.9
28.8
EBITDA / Interest Expense
8
21
19.1
160
111.1
31.9
(EBITDA - Capex) / Interest Expense
5.2
13.4
13.9
118.8
88.9
25.6
Per Share
Revenue per Share
35.3
23.9
Basic EPS
10.2
9.9
8.7
6.2
Diluted EPS
Book Value per Share
32.2
25.4
20.1
18.5
Tangible Book Value per Share
7.3
11
8.8
7.2
Cash per Share
7.8
5.8
Operating Cash Flow per Share
12.6
12
6.9
Free Cash Flow per Share
6.3
8.4
10.6
5.1
CapEx per Share
3.6
2.3
Weighted Avg. Shares Outstanding
4,450.5
4,197.1
4,501.3
4,511.6
Weighted Avg. Shares Outstanding Diluted
Common Size
R&D to Revenue
14.2%
14.8%
18.6%
14.9%
12.9%
14.6%
SG&A to Revenue
22.6%
23.5%
22.9%
26.2%
26.8%
29.6%
